Bolstering FDA Pathways for Reducing Death and Disease from Tobacco
Bibliographic Data
| ID | 15808474 |
|---|---|
| Authors | Scott Gottlieb (0000-0002-9455-3671, American Enterprise Institute, corresponding author), Mark Mcclellan (0000-0001-6636-5238, Duke Institute for Health Innovation) |
| Year | 2024 |
| Volume | 5 |
| Issue | 4 |
| Pages | e241233-e241233 |
| Publication date | 2024-04-11 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | JAMA Health Forum (JOURNAL) |
| Journal identifiers | ISSN: 2689-0186 • E-ISSN: 2689-0186 |
| Publisher | American Medical Association (PUBLISHER • US) |
| DOI | 10.1001/jamahealthforum.2024.1233 |
| PMID | 38602704 |
| OpenAlex | W4394727783 |
| Language | EN |
This JAMA Forum discusses the US Food and Drug Administration’s efforts to implement the 2009 Family Smoking Prevention and Tobacco Control Act through approval of products that demonstrate evidence to help smokers quit and to reduce their risk of relapse
Administration (probate law · Disease · Disease control · Environmental health · Family medicine · Food and drug administration · Pathology · Political science · Public health · Smoking cessation · Smoking prevention · Tobacco control · Tobacco use · Global Public Health Policies and Epidemiology · Law · Medicine · Nursing · Internal Medicine
| Highly cited | No |
|---|